Thomas Weaver – BioLeader Interview
Thomas Weaver BioLeader Interview - Thomas Weaver (March 2021) I am a native Wisconsinite who trained at the University in Madison (BSc in Math and Biochem, PhD in Oncology) but then moved to the UK 30 years ago as a postdoc at the MRC Laboratory of Molecular Biology in Cambridge. This was an exciting time in Cambridge with many labs just starting to apply large scale genetic and molecular screens to characterize biological processes from embryology to normal adult physiology and disease. The Human Genome Project was a natural extension of this endeavour and my involvement/interest was, and still [...]
Thomas Pedersen – BioLeader Interview
Thomas Pedersen BioLeader Interview - Thomas Pedersen (December 2020) Thomas has an academic background in skeletal muscle physiology and neuromuscular disease. He holds a PhD in Physiology from Aarhus University and he did two years of post doctoral work at Cambridge University. Thomas has years of experience in cellular electrophysiology and he has published more than 30 high-ranking papers including a first author paper in Science and several papers in The Journal of General Physiology. NMD Pharma was founded on scientific discoveries obtained in the Muscle Laboratory at Aarhus University in which Thomas holds a position as Associate Professor. Key [...]
Ian Campbell – BioLeader Interview
Ian Campbell BioLeader Interview - Ian Campbell (December 2020) Dr Ian Campbell is the recently appointed Chief Business Officer (CBO) with LifeArc and is responsible for business development and partnerships – a key component in accelerating the translation of life sciences innovation into benefits for patients. Ian was previously interim executive chair at Innovate UK, and before that Director for Health and Life Sciences. Prior to Innovate, Ian was Chief Executive of Arquer Diagnostics, a company developing and commercialising immunoassay tests for cancers of the urogenital tract. A graduate of the University of Glasgow, Ian holds a PhD in Biochemistry. [...]
Annalisa Jenkins – BioLeader Interview
Annalisa Jenkins BioLeader Interview - Annalisa Jenkins (November 2020) Annalisa Jenkins, M.B.B.S., F.R.C.P. is a biopharma thought leader with over 25 years of industry experience. Dr. Jenkins has extensive recent experience in building and financing biotech companies pursuing cures for the most challenging rare diseases to address important medical issues globally. She has consistently built and led teams advancing programs from scientific research through clinical development, regulatory approval, and into healthcare systems globally. In addition, she is an advocate for diversity and inclusion, particularly for women in science. Dr. Jenkins served as president and CEO of Dimension Therapeutics, a leading [...]
Alexis Peyroles – BioLeader Interview
Alexis Peyroles BioLeader Interview - Alexis Peyroles (November 2020) I am currently the CEO of OSE Immunotherapeutics, a French clinical stage listed biotech focused on immunotherapy; with innovative products under development in both immune-oncology and auto-immune diseases. Married with two children we are based near Paris. I graduated from EDHEC Business School and completed an executive MBA with Imperial College, London. Key milestones in your career journey to date? My early career was spent in Japan; after which I joined SANOFI where I had different roles in Finance and Business Development covering Asia and Eastern Europe. In 2005 I joined [...]
Claus Oleson – BioLeader Interview
Claus Oleson BioLeader Interview - Claus Oleson (October 2020) CEO and co-founder of STipe Therapeutics, a Biotech company developing a first in Class drug that harnesses the robust striking power of the innate immune system by sensitizing the STING pathway. Claus is 46 year's old living in Denmark and married to Mie Olesen and farther of 3 teenagers. Claus Elsborg Olesen earned his PhD in Physiology and Biophysics from Aarhus University in 2008 and has been engaged in both basic and applied research with an emphasis on structural biology and function of membrane proteins ever since. Dr. Olesen has identified [...]
Jonathan Tobin – BioLeader Interview
Jonathan Tobin BioLeader Interview - Jonathan Tobin (October 2020) Jonathan specialises in biotechnology investments and serves on the board of Arix portfolio companies Artios Pharma, Atox Bio, Stipe Therapeutics, Depixus, VelosBio, and Quench Bio. Prior to joining Arix Bioscience, Jonathan spent five years at Touchstone Innovations (formerly Imperial Innovations), where he was a Principal in the Healthcare Ventures team, and was involved with the formation of a number of early stage UK biotech companies. Previously, Jonathan worked at LifeArc (formerly MRC Technology), sourcing and evaluating new small molecule and antibody drug discovery projects. He has a first-class degree in biology [...]
Eliot Forster – BioLeader Interview
Eliot Forster BioLeader Interview - Eliot Forster (September 2020) Eliot has more than 28 years of experience in the pharmaceutical and biotechnology industry. He previously served as Chief Executive Officer of Immunocore, Creabilis Therapeutics and Solace Pharmaceuticals. Other previous roles include Head of Development and Operations for the EU and Asia at Pfizer. Eliot has also held several non-executive Director roles. He is an Honorary Visiting Professor at the University of Liverpool and Honorary International Visiting Professor at the University of Pavia. He is also Chairman of MedCity, a Board member of OSCHR (Office for Strategic Coordination of Health Research), [...]
Emma Sceats – BioLeader Interview
Emma Sceats BioLeader Interview - Emma Sceats (July 2020) Married with one daughter, enjoys running, keeping fit, reading business and economics books, cooking and enjoying a good glass of wine with friends and family. Key milestones in your career journey to date? Attending MIT; with its ‘anything is possible’ culture, stretching me beyond what I believed I was capable of. Joining the Licensing Team at Isis Innovation (now OUI) which provided an invaluable insight to deal structures, commercial IP and spinouts. Becoming the CEO of CN Bio Innovations in my early 30’s. Moving to Isogenica as CEO in September 2018. [...]
Tone Kvåle – BioLeader Interview
Tone Kvåle BioLeader Interview - Tone Kvåle (July 2020) For the last 25 years I have been leading finance teams in biotech and med-tech companies headquartered in Norway. I recently stepped down as a CFO of Nordic Nanovector ASA, Norway where I worked for more than 7 years. I am currently on the board of Bonesupport AB, Sweden and Chair of the Audit Committee. I have a diploma in Finance & Administration. On a personal level, I live outside of Oslo, Norway, and I have a partner and a grown-up son. Hobbies include cross country skiing, mountain hiking, orienteering and [...]